← Open Payments lookup

JEFFREY JONES: Open Payments

NPI 1669050159 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,816 in 65 payments from 9 companies in 2025. Trend: 2023 $945 · 2024 $1,049 · 2025 $1,816

Food & beverage: $1,816
CompanyPaymentsAmount
Gilead Sciences, Inc.19$510
Madrigal Pharmaceuticals11$411
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$248
Ipsen Biopharmaceuticals, Inc6$176
Mirum Pharmaceuticals, Inc.1$134
Novo Nordisk Inc2$129
Intercept Pharmaceuticals, Inc.7$120
Eton Pharmaceuticals, Inc.1$45
ORPHALAN INC2$43

Products named: REZDIFFRA, XIFAXAN, IQIRVO, Livmarli, Wegovy, OCALIVA, GALZIN, CUVRIOR.

Industry payments across TX — which companies pay providers there.